Evidence map›Paper›PMID 42437963›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Nuclear dysfunction in aging and neurodegeneration.

Abbigael Aday, Jack Tiller, Adarsh Melukote, Zachary C Walton, Anna King, Luke Castillo, Rakez Kayed, Mauro Montalbano

Abstract readReview
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abbigael AdayDepartment of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.
Jack TillerDepartment of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.
Adarsh MelukoteMitchell Center for Neurodegenerative Disorders, University of Texas Medical Branch, Galveston, Texas, USA.
Zachary C WaltonMitchell Center for Neurodegenerative Disorders, University of Texas Medical Branch, Galveston, Texas, USA.
Anna KingMitchell Center for Neurodegenerative Disorders, University of Texas Medical Branch, Galveston, Texas, USA.
Luke CastilloDepartment of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.
Rakez KayedDepartment of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.
Mauro MontalbanoDepartment of Neurology, University of Texas Medical Branch, Galveston, Texas, USA.ORCID https://orcid.org/0000-0002-0456-452X

Funding

Tau-RNA crosstalk: Alternative Poly-Adenylation (APA) Regulation in Alzheimer's DiseaseR03AG088929 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MONTALBANO, MAURO · 2024 to 2024
$320k
NIA NIH HHS 1R03AG088929-01NIA NIH HHS R03 AG088929
6 · The paper itself

Abstract

Neurodegenerative diseases are characterized by a loss of neuronal function and structure, often in a region-specific manner. Multiple factors contribute to neuronal dysfunction and death, including pathogenic protein buildup, protein mislocalization, and inflammation. Despite extensive research, the common mechanisms driving neurodegeneration remain incompletely understood, partly because pathological processes affect interconnected cellular components such as the cytosol, cytoskeleton, and nucleus. Emerging evidence indicates that changes in nuclear structure and function are not simply secondary to cellular stress but play key roles in aging and neurodegenerative disease progression. This review explores important aspects of nuclear dysfunction, including alterations in nuclear architecture, chromatin organization, nucleocytoplasmic transport, DNA damage responses, and inflammatory signaling. It further discusses how these processes converge to increase neuronal vulnerability and may extend beyond normal aging to promote neurodegeneration. Overall, this review highlights nuclear dysfunction as a significant factor in neuronal impairment and underscores the need for therapies targeting nuclear integrity.

Indexed as

AgingCell NucleusNeurodegenerative DiseasesAnimalsDNA DamageHumansNeuronsagingdementianeurodegenerationnuclear dysfunctionnucleocytoplasmic transportprotein aggregation

Identifiers

PMID42437963
PMCPMC13357693

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.